ProQuest Investments III L.P. 13D/13G Filings for Agile Therapeutics, Inc. (AGRX)

ProQuest Investments III L.P. 13D and 13G filings for Agile Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-10-01
4:25 pm
Sale
2020-09-18 13D Agile Therapeutics, Inc.
AGRX
ProQuest Investments III L.P. 2,110
4.800%
-421decrease
(-16.64%)
Filing